| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/138955708785740652 |
| P698 | PubMed publication ID | 18782050 |
| P50 | author | Anna Minarini | Q57078501 |
| P2093 | author name string | Maria Laura Bolognesi | |
| Carlo Melchiorre | |||
| Michela Rosini | |||
| Vincenzo Tumiatti | |||
| P433 | issue | 10 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 960-967 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Mini-Reviews in Medicinal Chemistry | Q3314982 |
| P1476 | title | From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease | |
| P478 | volume | 8 |
| Q92327129 | Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement |
| Q43172090 | Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA. |
| Q38022265 | Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. |
| Q53182177 | Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents. |
| Q36004978 | Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation. |
| Q42917723 | Inhibition of acetylcholinesterase by chromophore-linked fluorophosphonates |
| Q28820783 | Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease |
| Q38184970 | Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces |
| Q43151006 | Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations. |
| Q47253553 | Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease. |
| Q52643231 | Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice. |
| Q50859830 | The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon. |
Search more.